ICYMI, from #HTAi Global Policy Forum. Considering and communicating uncertainty in health technology assessment. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI, from #HTAi Global Policy Forum. Principles for deliberative processes in health technology assessment. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI, from #HTAi Global Policy Forum. How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes – From Theory to Action. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
ICYMI, from #HTAi Global Policy Forum. HOW CAN HEALTH SYSTEMS PREPARE FOR NEW AND EMERGING HEALTH TECHNOLOGIES? THE ROLE OF HORIZON SCANNING REVISITED. www.cambridge.org/core/journal... #IJTAHC #HTAI @htaiorg.bsky.social
ICYMI. Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI - An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI - Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI - Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI - An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI. Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI, from #HTAi Global Policy Forum. HOW CAN HEALTH SYSTEMS PREPARE FOR NEW AND EMERGING HEALTH TECHNOLOGIES? THE ROLE OF HORIZON SCANNING REVISITED. www.cambridge.org/core/journal... #IJTAHC #HTAI @htaiorg.bsky.social
ICYMI, from #HTAi Global Policy Forum. How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes – From Theory to Action. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
ICYMI, from #HTAi Global Policy Forum. Principles for deliberative processes in health technology assessment. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
ICYMI, from #HTAi Global Policy Forum. Considering and communicating uncertainty in health technology assessment. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social @dano-hta.bsky.social
New! Expanding access to sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the Ministry of Health Malaysia – a multiple HTA approach. www.cambridge.org/core/journal... #IJTAHC @htaiorg.bsky.social
New! Results of health technology assessments of orphan drugs in Germany—lack of added benefit, evidence gaps, and persisting unmet medical needs. www.cambridge.org/core/journal... #IJTAHC @htaiorg.bsky.social
New! How can managed entry agreements contribute to coverage decisions in Latin America? www.cambridge.org/core/journal... #IJTAHC @htaiorg.bsky.social
New! Adebrelimab versus serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis in China. www.cambridge.org/core/journal... #IJTAHC @htaiorg.bsky.social #HTA
New! THE INTERSECTION OF PRESCRIPTION DRUGS AND MEDICAL DEVICES: THE EVALUATION AND FUNDING CHALLENGES OF TWO CATEGORIES OF EMERGING HEALTH TECHNOLOGIES. www.cambridge.org/core/journal... #IJTAHC @htaiorg.bsky.social #HTA
Currently, our most read paper - The new definition of health technology assessment: A milestone in international collaboration. cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! Case studies of health economic analyses informing pharmaceutical health technology assessments for essential medicine selection and public-sector guidelines in South Africa. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! INAHTA Member Agency Stories Of Engaging, Adaptable, And Impactful HTA. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT OF A SCREENING RAPID TEST MTBI (GFAP AND UCH-L1 BLOOD BIOMARKERS) FOR MILD TRAUMATIC BRAIN INJURY. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New or repurposed: a novel classification system for the horizon scanning of innovative medicines. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! Cost-effectiveness analysis of a nonphysician-led, community-based blood pressure intervention in rural China based on CRHCP research. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social
New! How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies. www.cambridge.org/core/journal... #IJTAHC #HTA @htaiorg.bsky.social